Paul Saladino· MD
Insulin resistance/metabolic dysfunction (preventable and reversible) seems to be what is driving atherosclerosis.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Insulin resistance/metabolic dysfunction (preventable and reversible) seems to be what is driving atherosclerosis.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
i think that correcting insulin resistance which is also known as metabolic dysfunction should be at the center of every medical treatment paradigm
We should be treating insulin resistance. We should be treating metabolic dysfunction.